Example: Heart Attack

Clinical Trials on Staphylococcal Skin Infections

Total 58 results

NCT04287777

Completed

Safety and Efficacy of Mupirocin Gel in Children With Impetigo

Conditions: Impetigo
NCT03429595

Completed

Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo

Conditions: Impetigo
NCT03177993

Completed

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji

Conditions: Lymphatic Filariases; Scabies; Impetigo; Soil Transmitted Helminths
NCT02902822

Completed

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Conditions: Erysipelas; Impetigo; Herpes Zoster; Molluscum Contagiosum; Warts; Tinea; Melanoma; Actinic Keratosis; Basal Cell Carcinoma; Squamous Cell Carcinoma
NCT02814916

Recruiting

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Conditions: Methicillin-Resistant Staphylococcus Aureus; Bacterial Infections; Staphylococcal Skin Infections
NCT02775617

Completed

Azithromycin - Ivermectin Mass Drug Administration for Skin Disease

Conditions: Scabies; Yaws; Impetigo
NCT02582203

Completed

Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA

Conditions: Skin Diseases, Infectious; Staphylococcal Skin Infections
NCT02566928

Unknown status

Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence

Conditions: Methicillin-Resistant Staphylococcus Aureus; Recurrence; Staphylococcal Skin Infections; Antibiotic Resistance
NCT02334384

Completed

Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess

Conditions: Furunculosis
NCT02262819

Completed

Human Immunity Against Staphylococcus Aureus Skin Infection

Conditions: Staphylococcus Aureus Skin Infection
NCT02090764

Completed

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Conditions: Impetigo
NCT01943136

Unknown status

The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial

Conditions: Impetigo
NCT01814371

Completed

Individualized vs. Household MRSA Decolonization

Conditions: Staphylococcal Skin Infection; Abscess; Furunculosis; Staphylococcus Aureus; MRSA Infection
NCT01803035

Completed

A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo

Conditions: Non-bullous Impetigo
NCT01670032

Completed

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

Conditions: Impetigo
NCT01611909

Unknown status

Citriodiol® and Impetigo

Conditions: Impetigo
NCT01419184

Completed

Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA

Conditions: Staphylococcal Skin Infections
NCT01397461

Completed

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Conditions: Impetigo
NCT01367314

Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Conditions: Impetigo
NCT01198262

Completed

Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections

Conditions: Staphylococcus Aureus; Staphylococcal Skin Infections; Bacteremia
NCT01171326

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients

Conditions: Impetigo
NCT01153828

Completed

EU PV for Retapamulin-Prescribing

Conditions: Impetigo
NCT01126268

Completed

Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection

Conditions: Impetigo; Folliculitis; Secondarily Infected Eczema; Minor Soft Tissue Infections
NCT01105767

Completed

Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees

Conditions: Staphylococcus Aureus; MRSA Skin Infections; Staphylococcal Skin Infections
NCT01049438

Completed

A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

Conditions: Methicillin Resistant Staphylococcus Aureus Skin Infections
NCT01030731

Completed

Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease

Conditions: Staphylococcal Skin Infections; Streptococcal Infections
NCT01026558

Completed

A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients

Conditions: Obesity; Staphylococcal Skin Infections; Streptococcal Infections
NCT01026636

Completed

A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age

Conditions: Staphylococcal Skin Infections; Streptococcal Infections
NCT01026740

Completed

Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers

Conditions: Staphylococcal Skin Infections; Streptococcal Infections
NCT01018641

Completed

An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

Conditions: Bacterial Infections; Staphylococcal Vaccines; Immunotherapy, Active; Staphylococcal Skin Infections; Staphylococcal Infections
NCT00986856

Terminated

Fucidin® Cream in the Treatment of Impetigo

Conditions: Impetigo
NCT00948142

Completed

Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

Conditions: Skin Diseases, Bacterial
NCT00884728

Completed

Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory

Conditions: Scabies; Impetigo; Pyoderma; Streptococcal Infections
NCT00852540

Completed

Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

Conditions: Skin Infections, Bacterial
NCT00758862

Completed

The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo

Conditions: Secondarily Infected Traumatic Lesions (SITL); Impetigo
NCT00746109

Completed

Study of Wound Packing After Superficial Skin Abscess Drainage

Conditions: Abscess; Skin Diseases, Infectious; Boils; Furuncle; Carbuncle; Folliculitis; Cellulitis; Wounds
NCT00737269

Completed

A Complicated Skin and Soft-tissue Infection Patient Registry

Conditions: Staphylococcal Skin Infections; Diabetic Foot Infections; Surgical Wound Infection; Abscess; Cellulitis
NCT00731783

Completed

Staphylococcus Aureus Decolonization Study

Conditions: Staphylococcal Skin Infections; Abscesses; Furunculosis; Staphylococcus Aureus; MRSA Infection
NCT00730028

Completed

Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus

Conditions: Staphylococcal Infection
NCT00719810

Completed

Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections

Conditions: Skin Structure Infections; Bacterial Skin Diseases; Staphylococcal Skin Infections
NCT00646958

Completed

Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections

Conditions: Infectious Skin Diseases; Bacterial Skin Diseases; Staphylococcal Skin Infections; Streptococcal Infections; Abscess
NCT00626795

Completed

Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)

Conditions: Impetigo; Secondarily Infected Traumatic Lesions
NCT00560599

Completed

A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection

Conditions: Methicillin Resistant Staphylococcus Aureus Skin Infections
NCT00514527

Completed

A Study for Patients With Complicated Skin and Skin Structure Infections

Conditions: Staphylococcal Skin Infections; Wounds and Injuries; Abscess; Cellulitis; Streptococcal Infections
NCT00513799

Completed

The Natural History of Community-Associated MRSA Infections and Decolonization Strategies

Conditions: Abscesses; Furunculosis; Staphylococcus Aureus; Staphylococcal Skin Infections
NCT00492271

Terminated

First Time in Man Trial for Friulimicin B

Conditions: Community Acquired Pneumonia; Staphylococcal Skin Infections
NCT00475930

Completed

Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates

Conditions: Staphylococcus Aureus; Community-Acquired Infections; Staphylococcal Skin Infections
NCT00463801

Terminated

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Conditions: Staphylococcal Skin Infections
NCT00442832

Completed

TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Conditions: Staphylococcal Skin Infection
NCT00423657

Completed

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections

Conditions: Bacterial Infections

Clinical Trials on Staphylococcal Skin Infections

Recent CRA jobs

Sr Ctry Approval Spec, Ukraine

CRA Line Manager - Home Based - West Coast - CA/AZ/NV

ERP/HCM Application and Strategy Release Lead

Sales Enablement Manager - Remote Based

CRA (Level II) - France

Assoc Logistics Coord

Sr Scientist - Serology

Exec Director, Marketing - Evidera

Manager Contract Administration

Associate Manager Clinical Operations/Manager Clinical Operations/Senior Manager Clinical Operations - Home Based in DE, FL, GA, IL, IN, MI, NC, NJ, NY, OH, PA, RI, VA